Table 2.
The antibacterial activity of the synthesized HB(PDMA)s G2, G3, and G4. The results are described as the mean of the inhibition zone diameters (mm).
| Compounds |
Staphylococcus aureus (ATCC 29737) |
Bacillus subtilis (ATCC 6633) |
Escherichia coli (ATCC 8739) |
Candida albicans (ATCC 10231) |
|---|---|---|---|---|
| Mean Inhibition Zone (mm)* | ||||
| HB(PDMA)G2 | 20.0 ± 0.8 | 17.3 ± 0.2 | 15.3± 0.4 | 14.1 ± 0.2 |
| HB(PDMA)G3 | 27.0 ± 0.4 | 28.0 ± 0.4 | 24.8 ± 0.6 | 20.6 ± 1.2 |
| HB(PDMA)G4 | 28.0 ± 0.8 | 30.0 ± 0.0 | 25.0 ± 0.0 | 27.0 ± 0.0 |
| **AMC | 20.0 ± 0.0 | 17.0 ± 0.0 | - | - |
| TE | - | - | 22.0 ± 0.0 | - |
| Flu | - | - | - | 17.0 ± 0.2 |
*mm, millimeters. **AMC, Amoxicillin; TE, Tetracycline; Flu, Fluconazole (100 ppm).